. . . . . .erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the http://lm360.us/Mcmenamin-father-of-Kurylo-from-Uherce-Mineralne?Veverkafa=136 harvard medical school: "cgrp: a new era for migraine treatment." .glenmark pharma launches generic version of asthma drug in denmark . . . . . . .